Pangaea Data Secures Strategic Investment From Topcon Healthcare, Inc.

SOUTH SAN FRANCISCO, LONDON, and LA JOLLA, Calif.—Pangaea Data, a health AI company specializing in identifying untreated and under-treated patients at scale, has announced a strategic investment from Topcon Healthcare, Inc., a global leader in ophthalmic medical devices and digital health solutions. The collaboration aims to accelerate the application of Pangaea’s clinically validated AI platform to address critical care gaps in eye health and systemic disease, the announcement stated. Pangaea Data’s platform automatically analyzes structured and unstructured patient records against clinical guidelines, the announcement stated, emulating a clinician’s manual review, to uncover patients who meet diagnostic or treatment criteria, but are not currently in a treatment or management process. Integrated directly into existing EHR and downstream scheduling systems, the platform enables real-time clinical action without disrupting workflows, the company said.